- Reuters•8 hours ago
Drugmaker Perrigo Co Plc said on Monday it agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to privately held Royalty Pharma for up to $2.85 billion. Perrigo said it would delay the filing of its annual report until March, and would review past accounting practices, specifically its historical revenue recognition of its Tysabri sales. The company also said its chief financial officer, Judy Brown, was stepping down, to be replaced by an interim finance head.
- Associated Press•9 hours ago
TRENTON, N.J. (AP) — Several big drugmakers are trying to quell the furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.
- Motley Fool•9 hours ago
Forget about Valeant's EPS -- this figure is far more important.
VRX.TO : Summary for VALEANT PHARMACEUTICALS INTL IN - Yahoo Finance
Valeant Pharmaceuticals International, Inc. (VRX.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||20.93 - 22.30|
|52 Week Range||17.19 - 103.74|
|PE Ratio (TTM)||-3.34|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|